Syros Pharmaceuticals Inc (SYRS) has gained Thursday morning, with the stock climbing 22.73% in pre-market trading to 1.08. SYRS's short-term technical score of 30 indicates that the stock has traded less bullishly over the last month than 70% of stocks on the market. In the Biotechnology industry, which ranks 88 out of 146 industries, Syros Pharmaceuticals Inc ranks higher than 29% of stocks. Syros Pharmaceuticals Inc has fallen 3.30% over the past month, closing at $0.86 on July 7. During this period of time, the stock fell as low as $0.79 and as high as $1.03. SYRS has an average analyst recommendation of Strong Buy. The company has an average price target of $10.80.
SYRS has an Overall Score of 37. Find out what this means to you and get the rest of the rankings on SYRS!